Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shenmai injection for perioperative myocardial protection in off-pump coronary artery bypass surgery
ChiCTR2400086936Phase 4Recruiting
- Sponsor
- Dongyang People's Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of shenmai injection in coronary arteriosclerosis (2 arms), sponsored by Dongyang People's Hospital. Primary endpoint: Creatine kinase isoenzyme. Started Jul 2024; status: recruiting.
02
Drugs
shenmai injection
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR2400086936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086936.